Vysioneer is a Cambridge-based company dedicated to unlocking lesion-level insights on drug efficacy in the fight against cancer. Their mission is to ensure that every tumor is treated with the right medication at the right time, using AI technology to de-risk and accelerate clinical trials, ultimately reducing costs and improving patient outcomes.
Through their innovative approach, Vysioneer provides granular insights into the risk of local recurrence in brain metastases, helping healthcare professionals make informed decisions about follow-up and additional treatment options. Their work has been recognized by Stanford University, where VBrain was used to identify high-risk lesions and guide optimal management strategies.
Generated from the website